| | | | | | | | | | |
|
|
| Dockets Entered
On August 2, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1975N-0183H
|
| Health-Care Antiseptic Drug Products for OTC Human Use
|
|
|
| 1977N-0094
|
| OTC Internal Analgesic, Antipyretic & Antirheumatic Products
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1998D-1232
|
| Points to consider guidance documents on assayed&unassayed
|
|
|
| 1998F-0196
|
| Safe use of Selenium Yeast in Animal Feeds
|
|
|
| 2002D-0005
|
| Pharmacovigilance of Veterinary Medicinal Products
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing & Handling of Food
|
|
|
| 2006D-0108
|
| Guidance for Industry: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs
|
|
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
| 2007D-0125
|
| Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims
|
|
|
| 2007D-0213
|
| Guidance for Industry on Providing Regulatory Submissions in Electronic Format Receipt Date
|
|
|
| 2007D-0249
|
| Guidance for Industry: Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage
|
|
|
| 2007N-0215
|
| Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee
|
|
|
| 2007N-0217
|
| Licensure of Apheresis Blood Products; Public Workshop
|
|
|
| 2007N-0277
|
| Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
|
|
|
| 2007P-0147
|
| Use of the Term Natural Consistent with USDA's Food Safety and Inspection Service
|
|
|
| 1975N-0183H
|
| Health-Care Antiseptic Drug Products for OTC Human Use
|
|
|
| EC 4
|
| Advanced Enzyme Technologies Ltd.
|
| Vol #:
|
| 200
|
|
|
| 1977N-0094
|
| OTC Internal Analgesic, Antipyretic & Antirheumatic Products
|
|
|
| EC 1
|
| Advanced Enzyme Technologies Ltd.
|
| Vol #:
|
| 203
|
|
|
| EC 2
|
| Advanced Enzyme Technologies Ltd.
|
| Vol #:
|
| 203
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
| EC 3
|
| Ms. Rose Walters
|
| Vol #:
|
| 147
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET 20412
|
| INTE|MEDICA
|
| Vol #:
|
| 179
|
|
|
| LET 20413
|
| Michael's Naturopathic Programs
|
| Vol #:
|
| 179
|
|
|
| LET 20414
|
| Enzmatic Therapy
|
| Vol #:
|
| 179
|
|
|
| LET 20415
|
| Enzmatic Therapy
|
| Vol #:
|
| 179
|
|
|
| LET 20416
|
| Enzmatic Therapy
|
| Vol #:
|
| 179
|
|
|
| LET 20417
|
| Source Naturals
|
| Vol #:
|
| 179
|
|
|
| LET 20418
|
| IQ Organics LLC
|
| Vol #:
|
| 179
|
|
| | | | | | | |
|
|
| LET 20419
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20420
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20421
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20422
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20423
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20424
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20425
|
| Nature's Way
|
| Vol #:
|
| 179
|
|
|
| LET 20426
|
| American Institute of Eastern Medicine
|
| Vol #:
|
| 179
|
|
|
| LET 20427
|
| World Nutrition, Inc.
|
| Vol #:
|
| 179
|
|
|
| LET 20428
|
| American Institute of Medicine
|
| Vol #:
|
| 179
|
|
|
| LET 20429
|
| LA Weight Loss Centers, Inc.
|
| Vol #:
|
| 179
|
|
|
| LET 20430
|
| PatentHEALTH, LLC.
|
| Vol #:
|
| 179
|
|
|
| LET 20431
|
| M. Santana, LLC.
|
| Vol #:
|
| 179
|
|
|
| LET 20432
|
| SUNFOOD NUTRITION
|
| Vol #:
|
| 179
|
|
|
| LET 20433
|
| Carlson
|
| Vol #:
|
| 179
|
|
|
| LET 20434
|
| Carlson
|
| Vol #:
|
| 179
|
|
|
| LET 20435
|
| Carlson
|
| Vol #:
|
| 179
|
|
|
| LET 20436
|
| Carlson
|
| Vol #:
|
| 179
|
|
|
| LET 20437
|
| Carlson
|
| Vol #:
|
| 179
|
|
|
| LET 20438
|
| Carlson
|
| Vol #:
|
| 179
|
|
|
| LET 20439
|
| Immunotec Research Inc.
|
| Vol #:
|
| 179
|
|
|
| LET 20440
|
| Immunotec Research Inc.
|
| Vol #:
|
| 179
|
|
|
| LET 20441
|
| Gronek & Associates
|
| Vol #:
|
| 179
|
|
|
| LET 20442
|
| Natural Health International
|
| Vol #:
|
| 179
|
|
|
| LET 20443
|
| Natural Health International
|
| Vol #:
|
| 179
|
|
|
| LET 20444
|
| Natural Health International
|
| Vol #:
|
| 179
|
|
|
| LET 20445
|
| Natural Health International
|
| Vol #:
|
| 179
|
|
|
| LET 20446
|
| Natural Health International
|
| Vol #:
|
| 179
|
|
|
| LET 20447
|
| Natural Health International
|
| Vol #:
|
| 179
|
|
|
| LET 20448
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20449
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20450
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20451
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20452
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20453
|
| Enzmatic
|
| Vol #:
|
| 179
|
|
|
| LET 20454
|
| NBTY
|
| Vol #:
|
| 179
|
|
|
| LET 20455
|
| NBTY
|
| Vol #:
|
| 179
|
|
| | | | | | | | |
|
|
| C 3184
|
| L. Kerr
|
| Vol #:
|
| 38
|
|
|
| C 3185
|
| M. Mcbride
|
| Vol #:
|
| 38
|
|
|
| C 3186
|
| J. Brown
|
| Vol #:
|
| 38
|
|
|
| C 3187
|
| L. Mcbride
|
| Vol #:
|
| 38
|
|
|
| C 3188
|
| K. Shoop
|
| Vol #:
|
| 38
|
|
|
| C 3189
|
| E. Talmadge
|
| Vol #:
|
| 38
|
|
|
| C 3190
|
| N. Hediger
|
| Vol #:
|
| 38
|
|
|
| C 3191
|
| P. Eaton
|
| Vol #:
|
| 38
|
|
|
| C 3192
|
| N. Boyd
|
| Vol #:
|
| 38
|
|
|
| C 3193
|
| L. Ertz
|
| Vol #:
|
| 38
|
|
|
| C 3194
|
| S. English
|
| Vol #:
|
| 38
|
|
|
| C 3195
|
| D. Ort
|
| Vol #:
|
| 38
|
|
|
| C 3196
|
| D. Sanders
|
| Vol #:
|
| 38
|
|
|
| C 3197
|
| R. Wickless
|
| Vol #:
|
| 38
|
|
|
| C 3198
|
| B. Napier
|
| Vol #:
|
| 38
|
|
|
| C 3199
|
| H. De Jesus
|
| Vol #:
|
| 38
|
|
|
| C 3200
|
| C. Touby
|
| Vol #:
|
| 38
|
|
|
| C 3201
|
| S. Johnston
|
| Vol #:
|
| 38
|
|
|
| C 3202
|
| D. Southhard
|
| Vol #:
|
| 38
|
|
|
| C 3203
|
| K. Bilodeau
|
| Vol #:
|
| 38
|
|
|
| 2006D-0108
|
| Guidance for Industry: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs
|
|
|
| EC 2
|
| Mr. ian gottesman
|
| Vol #:
|
| 1
|
|
|
| EC 3
|
| Miss. Wendy Endres
|
| Vol #:
|
| 1
|
|
|
| EC 4
|
| PPTA
|
| Vol #:
|
| 1
|
|
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
|
|
| EXT 3
|
| NANOGEN, Inc
|
| Vol #:
|
| 3
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
| EC 1
|
| Mr. Brent Cowgill
|
| Vol #:
|
| 1
|
|
|
| EC 2
|
| Mr. Dwayne Hann
|
| Vol #:
|
| 1
|
|
|
| EC 3
|
| Mr. Philippe Burnham
|
| Vol #:
|
| 1
|
|
|
| EC 4
|
| American Academy of Allergy, Asthma and Immunology
|
| Vol #:
|
| 1
|
|
|
| EC 5
|
| Capital Allergy and Respiratory Disease Center
|
| Vol #:
|
| 1
|
|
|
| EC 6
|
| Graceway Pharmaceuticals, LLC
|
| Vol #:
|
| 1
|
|
|
| EC 7
|
| Graceway Pharmaceuticals, LLC
|
| Vol #:
|
| 1
|
|
|
| EC 8
|
| Ms. Judith Clemenko
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| EC 9
|
| Ms. Carol Farmer
|
| Vol #:
|
| 1
|
|
|
| EC 10
|
| Mr. roger moore
|
| Vol #:
|
| 1
|
|
|
| EC 11
|
| Mrs. Sara Morris
|
| Vol #:
|
| 1
|
|
|
| EC 12
|
| Ms. Arlene Leonard
|
| Vol #:
|
| 1
|
|
|
| EC 13
|
| Ms. Jan Faleski
|
| Vol #:
|
| 1
|
|
|
| EC 14
|
| Dr. Nicholas Gross
|
| Vol #:
|
| 1
|
|
|
| EC 15
|
| Mrs. Laura Podlich
|
| Vol #:
|
| 1
|
|
|
| EC 16
|
| International Pharmaceutical Aerosol Consortium
|
| Vol #:
|
| 1
|
|
|
| EC 17
|
| Richard J. Greene, M.D.
|
| Vol #:
|
| 1
|
|
|
| EC 18
|
| University of Pennsylvania
|
| Vol #:
|
| 1
|
|
|
| EC 19
|
| Dr. Natalie Pope
|
| Vol #:
|
| 1
|
|
|
| 2007D-0125
|
| Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims
|
|
|
| EC 1
|
| Salt Institute
|
| Vol #:
|
| 1
|
|
|
| EC 2
|
| Mr. Seth Kowitz
|
| Vol #:
|
| 1
|
|
|
| EC 3
|
| Ms. Vicki Huss
|
| Vol #:
|
| 1
|
|
|
| 2007D-0213
|
| Guidance for Industry on Providing Regulatory Submissions in Electronic Format Receipt Date
|
|
|
| EC 1
|
| Mr. Joe Public
|
| Vol #:
|
| 1
|
|
|
| EC 2
|
| GlaxoSmithKline
|
| Vol #:
|
| 1
|
|
|
| 2007D-0249
|
| Guidance for Industry: Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage
|
|
|
| EC 1
|
| Columbia University
|
| Vol #:
|
| 2
|
|
|
| 2007N-0215
|
| Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee
|
|
|
| EC 6
|
| University of Pennsylvania Health System
|
| Vol #:
|
| 1
|
|
|
| EC 7
|
| Mr. Charles Keyserling
|
| Vol #:
|
| 1
|
|
|
| EC 8
|
| Mr. Charles Keyserling
|
| Vol #:
|
| 1
|
|
|
| EC 9
|
| Vanderbilt University
|
| Vol #:
|
| 1
|
|
|
| EC 10
|
| Dr. Vivian Fonseca
|
| Vol #:
|
| 1
|
|
|
| EC 11
|
| CANYONS MEDICAL CENTER
|
| Vol #:
|
| 1
|
|
|
| EC 12
|
| Camino Medical Group
|
| Vol #:
|
| 1
|
|
|
| EC 13
|
| Dr. Robert Frederich
|
| Vol #:
|
| 1
|
|
|
| EC 14
|
| MidState Endocrine Associates
|
| Vol #:
|
| 1
|
|
|
| EC 15
|
| Dr. Alan Garber
|
| Vol #:
|
| 1
|
|
|
| EC 16
|
| Arbor Research Collaborative for Health
|
| Vol #:
|
| 1
|
|
|
| EC 17
|
| Dr. Pradip Jamnadas
|
| Vol #:
|
| 1
|
|
|
| EC 18
|
| Dr. Peter McCullough
|
| Vol #:
|
| 1
|
|